Tyramine in foods and monoamine oxidase inhibitor drugs : A crossroad where medicine, nutrition, pharmacy, and food industry convergeMCCABE-SELLERS, Beverly J; STAGGS, Cathleen G; BOGLE, Margaret L et al.Journal of food composition and analysis (Print). 2006, Vol 19, Num aou, issn 0889-1575, S58-S65Conference Paper

Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotineVILLEGIER, Anne-Sophie; SALOMON, Lucas; GRANON, Sylvie et al.Neuropsychopharmacology (New York, NY). 2006, Vol 31, Num 8, pp 1704-1713, issn 0893-133X, 10 p.Article

Involvement of alphal-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in ratVILLEGIER, Anne-Sophie; LOTFIPOUR, Shahrdad; BELLUZZI, James D et al.Psychopharmacologia. 2007, Vol 193, Num 4, pp 457-465, issn 0033-3158, 9 p.Article

Methylene blue and serotonin toxicity : inhibition of monoamine oxidase A (MAO A) confirms a theoretical predictionRAMSAY, R. R; DUNFORD, C; GILLMAN, P. K et al.British journal of pharmacology. 2007, Vol 152, Num 6, pp 946-951, issn 0007-1188, 6 p.Article

MAOI efficacy and safety in advanced stage treatment-resistant depression- : a retrospective studyAMSTERDAM, Jay D; SHULTS, Justine.Journal of affective disorders. 2005, Vol 89, Num 1-3, pp 183-188, issn 0165-0327, 6 p.Article

Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokineticsSHEN, Hong-Wu; CHAO WU; JIANG, Xi-Ling et al.Biochemical pharmacology. 2010, Vol 80, Num 1, pp 122-128, issn 0006-2952, 7 p.Article

Modification of the effects of 5-methoxyN,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitorsHALBERSTADT, Adam L; BUELL, Mahalah R; MASTEN, Virginia L et al.Psychopharmacologia. 2008, Vol 201, Num 1, pp 55-66, issn 0033-3158, 12 p.Article

Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonismSCHWARZ, M. J; HOUGHTON, P. J; ROSE, S et al.Pharmacology, biochemistry and behavior. 2003, Vol 75, Num 3, pp 627-633, issn 0091-3057, 7 p.Article

Remission in depression : definition and initial treatment approachesISRAEL, Joshua A.Journal of psychopharmacology. Supplement to ... 2006, Vol 20, Num 3, pp 5-10, issn 1359-7868, 6 p.Article

Monoamine oxidase inhibitors I-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicitySEYMOUR, C. B; MOTHERSILL, C; MOONEY, R et al.British journal of cancer. 2003, Vol 89, Num 10, pp 1979-1986, issn 0007-0920, 8 p.Article

New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitorsMATOS, Maria João; VINA, Dolores; JANEIRO, Patricia et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 17, pp 5157-5160, issn 0960-894X, 4 p.Article

MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarinsMATOS, Maria Joao; VAZQUEZ-RODRIGUEZ, Saleta; URIARTE, Eugenio et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 14, pp 4224-4227, issn 0960-894X, 4 p.Article

Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D₂/D₃ agonist quinpirole in rats: role of sigma and imidazoline I₂ receptorsCULVER, Kirsten E; SZECHTMAN, Henry.Psychopharmacologia. 2003, Vol 167, Num 2, pp 211-218, issn 0033-3158, 8 p.Article

Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitorsMATOS, Maria Joao; VINA, Dolores; PICCIAU, Carmen et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 17, pp 5053-5055, issn 0960-894X, 3 p.Article